COVID-19
Conditions
Interventions
Acute thuisbehandeling van luchtweginfecties (COVID-19)
Sponsors
ZilverenKruis
Eligibility
Age
18 Years to 99 Years
Inclusion criteria
Inclusion criteria: "Two types of patients can be included. Type 1: Patients with RTI/COVID-19 and hypoxemia and/or respiratory distress without signs of clinical instability who normally would be admitted to a hospital ward for supplemental oxygen treatment. Type 2: Patients with RTI/COVID-19 and hypoxemia and/or respiratory distress for whom hospitalisation is not considered desirable. Inclusion criteria: - Hypoxaemia (SpO2 24/min). - =18 years of age - Hemodynamically stable - Support at home: capable family member, or informal caregiver at home - Able to operate a pulse-oximeter - Proficient in Dutch (translator is allowed)"
Exclusion criteria
Exclusion criteria: "Type 1 and 2: -Dementia or severe psychiatric illness which renders the patient unable to follow study instructions -Known illness that prevents reliable pulse oximetry, e.g. severe anemia, Raynaud’s disease. Additional exclusion criteria for type 1 - Clinical condition requires more elaborate care than can be organised at home - Severe comorbidities or risk factors: COPD GOLD class III or IV; Chronic lung condition managed by a pulmonologist; insulin-dependent/poorly controlled diabetes; immunocompromised condition; history of deep vein thrombosis or pulmonary embolism; severe heart failure (NYHA III/IV); renal insufficiency (eGFR 35 kg/m2). Additional exclusion criteria for type 2 - Patient and physician decide -based on shared decision- to withhold specific treatment altogether when considered being in end-stage."
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Feasibility defined as reaching a stable, regionally supported intervention to monitor and optimally treat patients with COVID-19 (& other RTI) at home with the use of short-cylce evaluation roundes. We will use data of max. 30 patients. | — |
Secondary
| Measure | Time frame |
|---|---|
| We will collect data on patient characteristics, disease course (30 day follow-up, days alive out of hospital) and healthcare use through a combination of inclusion forms, GP medical file extractions, patient monitoring diaries, WHODAS 2.0 patient questionnaires. We will conduct and semi-structured interviews with involved healthcare workers and patients. | — |
Contacts
Public ContactJosi Boeijen
Department of General Practice & Nursing Science, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht
Outcome results
None listed